Sonata (Zaleplon) is a medication classified as Z-hypnotics, a subclass of pyrazolopyrimidines. It is indicated for the short-term treatment of insomnia, mainly characterized by sleep disturbance. Under the action of this medication the brain relaxes giving the chance to you to fall asleep.
Indication for use
Sonata (Zaleplon) can be taken by almost all adults for short-term treatment of severe forms of sleep disorders (difficulty falling asleep), leading to excessive fatigue, hampering daily activity and reducing performance.
Sonata (Zaleplon) is not recommended to use if you have:
• hypersensitivity to zaleplon or any of the components of the drug;
• liver failure of moderate severity;
• severe liver failure;
• severe renal failure;
• syndrome of night sleep apnea;
• severe pulmonary failure;
• alcohol or drug addiction;
• myasthenia gravis;
• acute respiratory failure;
• the period of breastfeeding;
• lactase deficiency, lactose intolerance, glucose-galactose malabsorption;
• children's age up to 18 years.
Dose and usage
Sonata (Zaleplon) is released in form of 5mg green and white gelatin capsules, 10mg pink and blue gelatin capsules.
The capsule is taken orally just before bedtime if the patient feels unable to sleep. Repeated intake overnight is not recommended. Single dose-10 mg. The maximum dose is 10 mg / day. Due to the increased sensitivity to hypnotics for elderly patients, the dose is 5 mg / day. Duration of application - no more than 2 weeks.
From the side of the central nervous system: often - headache, weakness, drowsiness, dizziness; anterograde amnesia is possible (especially when taken in high doses), accompanied by a violation of behavior, symptoms of latent depression, physical and mental dependence, drug abuse; mainly in elderly patients - paradoxical reactions (anxiety, agitation, irritability, aggressiveness, hallucinations, impaired perception, outbursts of anger, nightmares, behavioral disturbances).